1. Home
  2. EVTV vs IMRN Comparison

EVTV vs IMRN Comparison

Compare EVTV & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$2.12

Market Cap

11.5M

ML Signal

HOLD

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$0.73

Market Cap

12.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVTV
IMRN
Founded
2012
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
12.0M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
EVTV
IMRN
Price
$2.12
$0.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.2M
60.7K
Earning Date
11-20-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,696,856.00
$4,777,422.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
113.69
48.63
52 Week Low
$0.33
$0.68
52 Week High
$5.07
$2.39

Technical Indicators

Market Signals
Indicator
EVTV
IMRN
Relative Strength Index (RSI) 51.96 32.97
Support Level $1.96 $0.73
Resistance Level $2.26 $0.82
Average True Range (ATR) 0.33 0.05
MACD -0.09 -0.01
Stochastic Oscillator 35.69 7.09

Price Performance

Historical Comparison
EVTV
IMRN

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: